{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:34:49Z","timestamp":1793896489268,"version":"4.8.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012413","name":"The Catholic University of Korea Catholic Institute of Cell Therapy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["2022R1A2C2004517"],"award-info":[{"award-number":["2022R1A2C2004517"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jgo.2025.102335","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T06:45:06Z","timestamp":1754721906000},"page":"102335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Objectively measured physical function predicts mortality in older adults with acute myeloid leukemia treated by lower-intensity therapy: A prospective cohort study"],"prefix":"10.1016","volume":"16","author":[{"given":"Daehun","family":"Kwag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Sik","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Je","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2025.102335_bb0005","series-title":"SEER Cancer Statistics Review, 1975\u20132018 [Internet]","year":"2021"},{"key":"10.1016\/j.jgo.2025.102335_bb0010","series-title":"SEER*Explorer: An interactive website for SEER Cancer Statistics [Internet]. Surveillance Research Program","year":"2023"},{"key":"10.1016\/j.jgo.2025.102335_bb0015","article-title":"Impact of aging on acute myeloid leukemia epidemiology and survival outcomes: a real-world, population-based longitudinal cohort study","volume":"19","author":"Han","year":"2024","journal-title":"PloS One"},{"key":"10.1016\/j.jgo.2025.102335_bb0020","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/ijerph19042317","article-title":"Treatment pattern, financial burden, and outcomes in elderly patients with acute myeloid leukemia in Korea: a Nationwide cohort study","volume":"19","author":"Ha","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jgo.2025.102335_bb0025","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and Venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2025.102335_bb0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41408-022-00770-x","article-title":"Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis","volume":"12","author":"Kwag","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jgo.2025.102335_bb0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5045\/br.2021.2021152","article-title":"IDH1\/2 mutations in acute myeloid leukemia","volume":"57","author":"Byun","year":"2022","journal-title":"Blood Res"},{"key":"10.1016\/j.jgo.2025.102335_bb0040","series-title":"The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Acute Myeloid Leukemia V.3.2023","year":"2023"},{"key":"10.1016\/j.jgo.2025.102335_bb0045","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/leu.2012.303","article-title":"Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making","volume":"27","author":"Ferrara","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.jgo.2025.102335_bb0050","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1200\/JCO.2011.35.7525","article-title":"Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment","volume":"29","author":"Walter","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2025.102335_bb0055","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2141.2009.07663.x","article-title":"Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials","volume":"145","author":"Wheatley","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jgo.2025.102335_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100679","article-title":"Selection of initial therapy for newly-diagnosed adult acute myeloid leukemia: limitations of predictive models","volume":"44","author":"Walter","year":"2020","journal-title":"Blood Rev"},{"key":"10.1016\/j.jgo.2025.102335_bb0065","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1182\/blood-2017-09-746420","article-title":"Frailty and the management of hematologic malignancies","volume":"131","author":"Abel","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jgo.2025.102335_bb0070","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1182\/blood-2012-12-471680","article-title":"Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia","volume":"121","author":"Klepin","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jgo.2025.102335_bb0075","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood.2021013671","article-title":"Geriatric assessment predicts nonfatal toxicities and survival for intensively treated older adults with AML","volume":"139","author":"Min","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jgo.2025.102335_bb0080","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199503023320902","article-title":"Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability","volume":"332","author":"Guralnik","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2025.102335_bb0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jpsychores.2004.01.004","article-title":"Development of the Korean version of the geriatric depression scale and its short form among elderly psychiatric patients","volume":"57","author":"Bae","year":"2004","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.jgo.2025.102335_bb0090","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jgo.2025.102335_bb0095","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ajh.26061","article-title":"Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: a propensity score matched analysis stratified by risk of treatment-related mortality","volume":"96","author":"Maiti","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jgo.2025.102335_bb0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/sim.4026","article-title":"Several methods to assess improvement in risk prediction models: extension to survival analysis","volume":"30","author":"Chambless","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.jgo.2025.102335_bb0105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41512-019-0057-6","article-title":"A comparison of landmark methods and time-dependent ROC methods to evaluate the time-varying performance of prognostic markers for survival outcomes","volume":"3","author":"Bansal","year":"2019","journal-title":"Diagnost Prognost Res"},{"key":"10.1016\/j.jgo.2025.102335_bb0110","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jgo.2025.102335_bb0115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1182\/blood-2015-01-621664","article-title":"International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts","volume":"126","author":"Dombret","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jgo.2025.102335_bb0120","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1200\/JCO.2011.38.9429","article-title":"Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia","volume":"30","author":"Kantarjian","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2025.102335_bb0125","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000912","article-title":"BCL2 inhibition: a new paradigm for the treatment of AML and beyond","volume":"7","author":"Wei","year":"2023","journal-title":"Hemasphere"},{"key":"10.1016\/j.jgo.2025.102335_bb0130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00277-023-05102-y","article-title":"Shorter duration of venetoclax administration to 14 days has same efficacy and better safety profile in treatment of acute myeloid leukemia","volume":"102","author":"Aiba","year":"2023","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jgo.2025.102335_bb0135","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1182\/blood-2022-168036","article-title":"Real world effectiveness of \u201c7 + 3\u201d intensive chemotherapy vs Venetoclax and Hypomethylating agent for initial therapy in adult acute myeloid leukemia","volume":"140","author":"Matthews","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jgo.2025.102335_bb0140","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1017\/S0033291709992285","article-title":"Depression and cancer mortality: a meta-analysis","volume":"40","author":"Pinquart","year":"2010","journal-title":"Psychol Med"},{"key":"10.1016\/j.jgo.2025.102335_bb0145","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood.2020005498","article-title":"Geriatric assessment and survival among older adults receiving postremission therapy for acute myeloid leukemia","volume":"136","author":"Saad","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jgo.2025.102335_bb0150","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/bloodadvances.2021006872","article-title":"Geriatric assessment for older adults receiving less-intensive therapy for acute myeloid leukemia: report of CALGB 361101","volume":"6","author":"Ritchie","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jgo.2025.102335_bb0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/NCC.0000000000001164","article-title":"Cognitive function in adults with acute myeloid leukemia treated with chemotherapy: a systematic review","volume":"47","author":"Chan","year":"2024","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.jgo.2025.102335_bb0160","first-page":"485","article-title":"Cancer-related cognitive impairment in older adults with acute myeloid leukemia treated with hypomethylating agents and venetoclax chemotherapy: a longitudinal descriptive study","volume":"32","author":"Chan","year":"2024","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jgo.2025.102335_bb0165","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jgo.2019.01.001","article-title":"The added value of an assessment of the patient\u2019s hand grip strength to the comprehensive geriatric assessment in G8-abnormal older patients with cancer in routine practice","volume":"10","author":"Lycke","year":"2019","journal-title":"J Geriatr Oncol"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406825001511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406825001511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:52:02Z","timestamp":1765975922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406825001511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1879406825001511"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2025.102335","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Objectively measured physical function predicts mortality in older adults with acute myeloid leukemia treated by lower-intensity therapy: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2025.102335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102335"}}